Exploring the anti‐cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review

Abstract

Background The most common and deadly cancer in female is breast cancer (BC) and new incidence and deaths related to this cancer are rising. Aims Several issues, that is, high cost, toxicity, allergic reactions, less efficacy, multidrug resistance, and the economic cost of conventional anti‐cancer therapies, has prompted scientists to discover innovative approaches and new chemo‐preventive agents. Materials Numerous studies are being conducted on plant‐based and dietary phytochemicals to discover new‐fangled and more advanced therapeutic approaches for BC management. Result We have identified that natural compounds modulated many molecular mechanisms and cellular phenomena, including apoptosis, cell cycle progression, cell proliferation, angiogenesis and metastasis, up‐regulation of tumor‐suppressive genes, and down‐regulation of oncogenes, modulation of hypoxia, mammosphere formation, onco‐inflammation, enzymatic regulation, and epigenetic modifications in BC. We found that a number of signaling networks and their components such as PI3K/Akt/mTOR, MMP‐2 and 9, Wnt/‐catenin, PARP, MAPK, NF‐κB, Caspase‐3/8/9, Bax, Bcl2, Smad4, Notch1, STAT3, Nrf2, and ROS signaling can be regulated in cancer cells by phytochemicals. They induce up‐regulation of tumor inhibitor microRNAs, which have been highlighted as a key player for ani‐BC treatments followed by phytochemical supplementation. Conclusion Therefore, this collection offers a sound foundation for further investigation into phytochemicals as a potential route for the development of anti‐cancer drugs in treating patients with BC.

Amazon Plant‐Derived Compounds Suppressing Dengue NS5 Protein: Insights from Computational Drug Development and Network Pharmacology Approach

“…All selected phytochemicals from NuBBE Database showed a higher absorption value than the control drug, showing an excellent characteristics for selecting lead compounds. [87] Blood Brain Barrier (BBB) is considered as a shield, protecting the brain from foreign substances. Drugs having logBB value > 0.3 considered as highly permeable to BBB.…”

“…Absorption value less than 30 % of a drug candidate regards as poorly absorbed drug. All selected phytochemicals from NuBBE Database showed a higher absorption value than the control drug, showing an excellent characteristics for selecting lead compounds [87] . Blood Brain Barrier (BBB) is considered as a shield, protecting the brain from foreign substances.…”

Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent

“…A notable statistic underscores the significance of natural origins, indicating that 51% of the 1211 newly approved small-molecule drugs worldwide between 1981 and 2014 were derived from natural products [ 20 ]. Polyphenols have been known to have various preventive effects on different conditions such as diabetes, cardiovascular disease, neurodegenerative disorder, and obesity [ 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 ], and have been extensively studied to determine their anticancer potential and incorporate them into cancer treatment modalities like chemotherapy and targeted therapy [ 30 , 31 , 32 , 33 ].…”

Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights

“…Consequently, it is no surprise that the scientific community's interest in discovering a natural anticancer agent has considerably increased during the last few decades (Talib et al, 2022). The NCI began a screening trial for plant-based anticancer drug development in 1960, and more than 50-70% of the anti-cancer drugs are generated from natural compounds (Sak, 2022;Sohel et al, 2023). This is because plant-based compounds with natural properties could be a safe and efficient treatment method for managing various types of human cancer Solowey et al, 2014).…”